Literature DB >> 4394735

Immunological treatment of leukaemias.

G Mathé.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 4394735      PMCID： PMC1820113          DOI： 10.1136/bmj.4.5733.487

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM).

Authors:  G MATHE; J L AMIEL; L SCHWARZENBERG; A CATTAN; M SCHNEIDER
Journal:  Br Med J       Date:  1963-12-28

2.  [REDUCTION OF THE PLASMA CONCENTRATION OF THE CHARLOTTE FRIEND LEUKEMOGENIC VIRUS BY ADOPTIVE IMMUNOTHERAPY (GRAFT OF ALLOGENIC BONE MARROW)].

Authors:  G MATHE; J L AMIEL
Journal:  C R Hebd Seances Acad Sci       Date:  1964-12-09

3.  [Bone marrow grafts after total irradiation of leukemic mice followed by administration of an antimitotic agent to reduce the incidence of a secondary syndrome and to enhance the antileukemic effect].

Authors:  G MATHE; J L AMIEL; J NIEMETZ
Journal:  C R Hebd Seances Acad Sci       Date:  1962-05-14

4.  The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens.

Authors:  R Motta
Journal:  Rev Eur Etud Clin Biol       Date:  1970-02

5.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

6.  [Local elective immunotherapy of L 1210 ascitic leukemia. Analysis of factors of its efficacy].

Authors:  G Mathé; L Schwarzenberg
Journal:  Eur J Cancer       Date:  1968-05       Impact factor: 9.162

7.  [Rupture of immune tolerance by total irradiation].

Authors:  S Orbach-Arbouys
Journal:  Rev Fr Etud Clin Biol       Date:  1968-12

8.  New antigens in human leukaemic cells and antibody in the serum of leukaemic patients.

Authors:  J F Dore; R Motta; L Marholev; I Hrsak; H Colas de la Noue; G Seman; F De Vassal; G Mathé
Journal:  Lancet       Date:  1967-12-30       Impact factor: 79.321

9.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640
  9 in total
  7 in total

1.  Leukaemia-associated antigens in man. Detection by antibodies in maternal sera.

Authors:  P R Cullen; D Y Mason
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

2.  Eradication of lymphoma cells with allogeneic immune peritoneal cells.

Authors:  H F Dullens; W den Otter
Journal:  Experientia       Date:  1973-04-15

3.  Evidence for antigenicity in human tumours with reference both to melanoma and acute leukemia.

Authors:  G H Fairley
Journal:  Proc R Soc Med       Date:  1971-10

4.  Prospects for immunotherapy of cancer: experience in experimental systems.

Authors:  P Alexander
Journal:  Br Med J       Date:  1970-11-21

5.  Transience of immune responses to tumour antigens in man.

Authors:  J L Odili; G Taylor
Journal:  Br Med J       Date:  1971-12-04

6.  Histological evidence of tumour rejection after active immunotherapy in human malignant disease.

Authors:  G Taylor; J L Odili
Journal:  Br Med J       Date:  1972-04-22

7.  Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.

Authors:  M F Woodruff; M P Inchley; N Dunbar
Journal:  Br J Cancer       Date:  1972-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.